A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment

NCT00773240 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

276

Enrollment

INDUSTRY

Sponsor class

Conditions

Grass Pollen Allergy

Interventions

DRUG: Grazax
DRUG: placebo

Sponsor

ALK-Abelló A/S